Treatment Innovations

Beyond the "Spaghetti": How Talus Bio is Revolutionizing Drug Discovery by Ignoring Protein Folding

• Treatment Innovations

Beyond the "Spaghetti": How Talus Bio is Revolutionizing Drug Discovery by Ignoring Protein Folding

Evan Lee Salim September 30, 2026

In the high-stakes world of pharmaceutical research, the quest to identify small-molecule drugs that can bind to...

Read More Read more about Beyond the "Spaghetti": How Talus Bio is Revolutionizing Drug Discovery by Ignoring Protein Folding

Siemens Healthineers Launches Innovance D-Dimer 2.0: A New Standard in Thrombotic Disorder Diagnostics

• Treatment Innovations

Siemens Healthineers Launches Innovance D-Dimer 2.0: A New Standard in Thrombotic Disorder Diagnostics

Ali Ikhwan September 30, 2026

In a significant advancement for emergency medicine and laboratory diagnostics, Siemens Healthineers has announced the global launch...

Read More Read more about Siemens Healthineers Launches Innovance D-Dimer 2.0: A New Standard in Thrombotic Disorder Diagnostics

Liver Toxicity Concerns Cloud Future of Bristol Myers Squibb’s Admilparant Program

• Treatment Innovations

Liver Toxicity Concerns Cloud Future of Bristol Myers Squibb’s Admilparant Program

Ali Ikhwan September 30, 2026

By Jonathan Gardner | Sept. 30, 2026 The pharmaceutical landscape is currently navigating a period of heightened...

Read More Read more about Liver Toxicity Concerns Cloud Future of Bristol Myers Squibb’s Admilparant Program

The Future of Cardiac Rehabilitation: Why Patient-Centricity is the Catalyst for At-Home Care

• Treatment Innovations

The Future of Cardiac Rehabilitation: Why Patient-Centricity is the Catalyst for At-Home Care

Iffa Jayyana September 30, 2026

The paradigm of cardiac rehabilitation is undergoing a seismic shift. Traditionally tethered to clinical environments, the recovery...

Read More Read more about The Future of Cardiac Rehabilitation: Why Patient-Centricity is the Catalyst for At-Home Care

Eden Radioisotopes Secures Major State Backing for $1.4bn Landmark Medical Reactor in New Mexico

• Treatment Innovations

Eden Radioisotopes Secures Major State Backing for $1.4bn Landmark Medical Reactor in New Mexico

Lina Hope September 30, 2026

In a significant leap forward for domestic healthcare infrastructure and nuclear medicine, Eden Radioisotopes has officially secured...

Read More Read more about Eden Radioisotopes Secures Major State Backing for $1.4bn Landmark Medical Reactor in New Mexico

Novo Nordisk Escalates Obesity Drug Arms Race with Strategic Acquisition of Hengrui’s HRS-1596

• Treatment Innovations

Novo Nordisk Escalates Obesity Drug Arms Race with Strategic Acquisition of Hengrui’s HRS-1596

Ammar Sabilarrohman September 30, 2026

In a bold move to reassert its dominance in the burgeoning obesity therapeutics market, Danish pharmaceutical giant...

Read More Read more about Novo Nordisk Escalates Obesity Drug Arms Race with Strategic Acquisition of Hengrui’s HRS-1596

The Oral Frontier: Overcoming the Bioavailability Challenge in PROTAC Drug Development

• Treatment Innovations

The Oral Frontier: Overcoming the Bioavailability Challenge in PROTAC Drug Development

Sagoh September 29, 2026

The landscape of modern pharmacology shifted fundamentally in May 2026. With the U.S. FDA’s landmark approval of...

Read More Read more about The Oral Frontier: Overcoming the Bioavailability Challenge in PROTAC Drug Development

Bridging the Gap: New Dexcom Report Exposes Critical Barriers in Type 2 Diabetes Care

• Treatment Innovations

Bridging the Gap: New Dexcom Report Exposes Critical Barriers in Type 2 Diabetes Care

Rifan Muazin September 29, 2026

As the global medical community converges on Milan for the 2026 European Association for the Study of...

Read More Read more about Bridging the Gap: New Dexcom Report Exposes Critical Barriers in Type 2 Diabetes Care

Bridging the Gap: Fuse Oncology and AMP Launch Strategic Proof-of-Concept for Streamlined Prostate Cancer Care

• Treatment Innovations

Bridging the Gap: Fuse Oncology and AMP Launch Strategic Proof-of-Concept for Streamlined Prostate Cancer Care

Suro Senen September 29, 2026

In a move aimed at fundamentally restructuring the operational landscape of radiation oncology, Fuse Oncology has entered...

Read More Read more about Bridging the Gap: Fuse Oncology and AMP Launch Strategic Proof-of-Concept for Streamlined Prostate Cancer Care

Revolutionizing Pediatric ADHD Care: Firefly Neuroscience and NeuroSigma Forge Strategic Partnership

• Treatment Innovations

Revolutionizing Pediatric ADHD Care: Firefly Neuroscience and NeuroSigma Forge Strategic Partnership

Muslim September 29, 2026

In a significant move to reshape the landscape of pediatric mental health, Firefly Neuroscience and NeuroSigma have...

Read More Read more about Revolutionizing Pediatric ADHD Care: Firefly Neuroscience and NeuroSigma Forge Strategic Partnership